Literature DB >> 2834053

Clinical trials in primary hepatocellular carcinoma: current status and future directions.

S R Nerenstone1, D C Ihde, M A Friedman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 2834053     DOI： 10.1016/0305-7372(88)90007-2

Source DB:  PubMed          Journal:  Cancer Treat Rev        ISSN： 0305-7372            Impact factor:   12.111


× No keyword cloud information.
  36 in total

Review 1.  Chemotherapy for upper gastrointestinal tumours.

Authors:  A L Thomas; K O'Byrne; W P Steward
Journal:  Postgrad Med J       Date:  2000-06       Impact factor: 2.401

Review 2.  Management of hepatocellular carcinoma.

Authors:  P Fitzmorris; M Shoreibah; B S Anand; A K Singal
Journal:  J Cancer Res Clin Oncol       Date:  2014-08-27       Impact factor: 4.553

3.  Non-surgical treatment of hepatocellular carcinoma.

Authors:  Philip J Johnson
Journal:  HPB (Oxford)       Date:  2005       Impact factor: 3.647

4.  The treatment of primary and metastatic hepatic neoplasms using percutaneous cryotherapy.

Authors:  Mitchell T Smith; Charles E Ray
Journal:  Semin Intervent Radiol       Date:  2006-03       Impact factor: 1.513

Review 5.  Hepatocellular carcinoma.

Authors:  S Badvie
Journal:  Postgrad Med J       Date:  2000-01       Impact factor: 2.401

6.  Epirubicin, cisplatin, 5-FU combination chemotherapy in sorafenib-refractory metastatic hepatocellular carcinoma.

Authors:  Ji Eun Lee; Si Hyun Bae; Jong Young Choi; Seung Kew Yoon; Young Kyoung You; Myung Ah Lee
Journal:  World J Gastroenterol       Date:  2014-01-07       Impact factor: 5.742

Review 7.  Hepatocellular carcinoma: is current therapy really altering outcome?

Authors:  P J Johnson
Journal:  Gut       Date:  2002-10       Impact factor: 23.059

8.  Role of Caveolin-1 in Indomethacin-induced Death of Human Hepatoadenocarcinoma SK-Hep1 Cells.

Authors:  Kyung-Nam Kim; Ju-Hee Kang; Sung-Vin Yim; Chang-Shin Park
Journal:  Korean J Physiol Pharmacol       Date:  2008-08-31       Impact factor: 2.016

Review 9.  Nanoparticles for targeted delivery of therapeutics and small interfering RNAs in hepatocellular carcinoma.

Authors:  Jaleh Varshosaz; Maryam Farzan
Journal:  World J Gastroenterol       Date:  2015-11-14       Impact factor: 5.742

10.  Combination chemotherapy of doxorubicin and paclitaxel for hepatocellular carcinoma in vitro and in vivo.

Authors:  Cheng Jin; Haimin Li; Yong He; Min He; Ling Bai; Yunxin Cao; Wenjie Song; Kefeng Dou
Journal:  J Cancer Res Clin Oncol       Date:  2009-08-20       Impact factor: 4.553
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.